Li Jing-zhu, Li Xiao-zheng, Wang Xiao-min, Wang Ming-shan, Yu Hai-fang, Shi Fei, Miao Dan, Bi Yan-lin
Department of Anesthesiology, Qingdao Municipal Hospital, Qingdao 266071, China.
Zhonghua Yi Xue Za Zhi. 2013 Jul 16;93(27):2152-4.
To explore the effects of parecoxib sodium analgesia on serum concentrations of neuron-specific enolase (NSE) and S-100β and postoperative cognitive function of elderly patients undergoing acute replacement of femoral head.
After the approval of institutional review board and the provision of informed consent, 80 patients over 70 years old, undergoing acute replacement of femoral head under combined spinal and epidural anesthesia and midazolam sedation at Qingdao Municipal Hospital and Qingdao Hiser Medical Center from January 2011 to May 2012, were randomly assigned into control group (group C, n = 40) and parecoxib group (group P, n = 40). In group P, parecoxib sodium 20/40 mg (based on weight 50 kg) was administered via an intravenous injection after admission with 12 hours intervals for six times. In group C, morphine 2/4 mg was given initially. Additional morphine 2 mg was given to maintain the pain visual analog scale (VAS) of 3 points or less in both groups. Primary observation indices: (1) postoperative time and additional amount of morphine; (2) rate of postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) at 3 days, 1 week, 3 months and 6 months postoperation (T1-T4); (3) se rum levels of NSE and S-100β were measured at the timepoints of before analgesia (t0), before anesthesia (t1), end of surgery (t2) and 6 hours, 24 hours, 48 hours postoperation (t3-t5); (4) other serious complications.
Compared with group C, the additional amount of morphine, postoperative time, rate of POD and POCD at T1-T4, the level of NSE at t2-t5 and S-100β at t1-t5 were lower in group P (P < 0.05). No other serious complications were observed.
Parecoxib sodium analgesia reduces the rate of POD and POCD in elderly patients with neuroprotective effects.
探讨帕瑞昔布钠镇痛对老年股骨头急性置换患者血清神经元特异性烯醇化酶(NSE)和S-100β浓度及术后认知功能的影响。
经机构审查委员会批准并获得知情同意后,选取2011年1月至2012年5月在青岛市市立医院和青岛海慈医疗中心行腰硬联合麻醉及咪达唑仑镇静下进行股骨头急性置换的80例70岁以上患者,随机分为对照组(C组,n = 40)和帕瑞昔布组(P组,n = 40)。P组患者入院后静脉注射帕瑞昔布钠20/40 mg(基于体重50 kg),每12小时1次,共6次。C组患者初始给予吗啡2/4 mg。两组均追加吗啡2 mg以维持疼痛视觉模拟评分(VAS)在3分及以下。主要观察指标:(1)术后时间及吗啡追加量;(2)术后3天、1周、3个月和6个月(T1-T4)的术后谵妄(POD)发生率和术后认知功能障碍(POCD)发生率;(3)在镇痛前(t0)、麻醉前(t1)、手术结束时(t2)以及术后6小时、24小时、48小时(t3-t5)测定血清NSE和S-100β水平;(4)其他严重并发症。
与C组相比,P组吗啡追加量、术后时间、T1-T4时的POD和POCD发生率、t2-t5时的NSE水平以及t1-t5时的S-100β水平均较低(P < 0.05)。未观察到其他严重并发症。
帕瑞昔布钠镇痛可降低老年患者POD和POCD发生率,具有神经保护作用。